Donor-derived hepatitis C virus infections: Are they "high-risk" anymore?

被引：0
|
作者：
Kim, Arthur Y. [1 ]
机构：
[1] Harvard Med Sch, Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02115 USA
来源：
TRANSPLANT INFECTIOUS DISEASE | 2017年 / 19卷 / 02期
关键词：
UNITED-STATES; TRANSPLANTATION; TRANSMISSION; SOFOSBUVIR; EPIDEMIC;
D O I：
10.1111/tid.12679
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Is This Organ Donor Safe? Donor-Derived Infections in Solid Organ Transplantation
    Fischer, Staci A.
    SURGICAL CLINICS OF NORTH AMERICA, 2019, 99 (01) : 117 - +
  • [42] Successful treatment of donor-derived hepatitis C viral infection in three transplant recipients from a donor at increased risk for bloodborne pathogens
    Shah, Ashesh P.
    Cameron, Andrew
    Singh, Pooja
    Frank, Adam M.
    Fenkel, Jonathan M.
    TRANSPLANT INFECTIOUS DISEASE, 2017, 19 (02)
  • [43] Hepatitis A virus infection in high-risk subjects
    Barrientos-Gutierrez, Tonatiuh
    Brizuela-Alcantara, Diana
    Chavez-Tapia, Norberto C.
    ANNALS OF HEPATOLOGY, 2011, 10 (04) : 578 - 579
  • [44] HIV, Hepatitis B Virus, and Hepatitis C Virus Prevalence Among High-Risk Populations in South India
    Dinesha, Thongadi Ramesh
    Boobalan, Jayaseelan
    Sivamalar, Sathasivam
    Solomon, Sunil S.
    Poongulali, Selvamuthu
    Pradeep, Ambrose
    Murugavel, Kailapuri G.
    Balakrishnan, Pachamuthu
    Smith, Davey M.
    Saravanan, Shanmugam
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 (04) : 327 - 328
  • [45] Non-Standard Risk Donors and Risk of Donor-Derived Infections: From Evaluation to Therapeutic Management
    Grossi, Paolo A.
    Wolfe, Cameron
    Peghin, Maddalena
    TRANSPLANT INTERNATIONAL, 2024, 37
  • [46] Performance and modification of EGCRISC among hepatitis C virus high-risk groups
    El-Ghitany, E. M.
    Alkassabany, Y. M.
    Farghaly, A. G.
    EPIDEMIOLOGY AND INFECTION, 2020, 148
  • [47] Donor-Derived Genotype 4 Hepatitis E Virus Infection, Hong Kong, China, 2018
    Sridhar, Siddharth
    Cheng, Vincent C. C.
    Wong, Shuk-Ching
    Yip, Cyril C. Y.
    Wu, Shusheng
    Lo, Anthony W., I
    Leung, Kit-Hang
    Mak, Winger W. N.
    Cai, Jianpiao
    Li, Xin
    Chan, Jasper F. W.
    Lau, Susanna K. P.
    Woo, Patrick C. Y.
    Lai, Wai-Ming
    Kwan, Tze-Hoi
    Au, Timmy W. K.
    Lo, Chung-Mau
    Wong, Sally C., V
    Yuen, Kwok-Yung
    EMERGING INFECTIOUS DISEASES, 2019, 25 (03) : 425 - 433
  • [48] Hepatitis C Virus Screening of High-Risk Patients in a Canadian Emergency Department
    Ragan, Kelsey
    Pandya, Anjali
    Holotnak, Tristan
    Koger, Katrina
    Collins, Neil
    Swain, Mark G.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 2020
  • [49] HEPATITIS-C VIRUS-ANTIBODIES IN HIGH-RISK SAUDI GROUPS
    BAHAKIM, H
    BAKIR, TMF
    ARIF, M
    RAMIA, S
    VOX SANGUINIS, 1991, 60 (03) : 162 - 164
  • [50] SEROPREVALENCE OF ANTIBODIES TO HEPATITIS-C VIRUS IN HIGH-RISK HOSPITAL PERSONNEL
    COOPER, BW
    KRUSELL, A
    TILTON, RC
    GOODWIN, R
    LEVITZ, RE
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1992, 13 (02): : 82 - 85
12345